Barclays PLC Azenta, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Azenta, Inc. stock. As of the latest transaction made, Barclays PLC holds 99,958 shares of AZTA stock, worth $3.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,958

Previous 169,524 41.04%

Holding current value

$3.65 Million

Previous $8.21 Million 39.13%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$40.37 - $51.57 $2.81 Million - $3.59 Million	-69,566 Reduced 41.04%	99,958 $5 Million
Q3 2024 Nov 15, 2024	BUY	$45.84 - $62.29 $3.21 Million - $4.36 Million	69,997 Added 70.33%	169,524 $8.21 Million
Q2 2024 Aug 14, 2024	SELL	$50.27 - $59.04 $8.53 Million - $10 Million	-169,690 Reduced 63.03%	99,527 $5.24 Million
Q1 2024 May 15, 2024	BUY	$57.82 - $67.51 $2.87 Million - $3.35 Million	49,608 Added 22.59%	269,217 $16.2 Million
Q4 2023 Feb 15, 2024	BUY	$44.02 - $66.3 $58,458 - $88,046	1,328 Added 0.61%	219,609 $14.3 Million
Q3 2023 Nov 07, 2023	SELL	$44.08 - $57.76 $1.8 Million - $2.36 Million	-40,872 Reduced 15.77%	218,281 $11 Million
Q2 2023 Aug 03, 2023	BUY	$36.45 - $46.68 $7.37 Million - $9.44 Million	202,162 Added 354.73%	259,153 $12.1 Million
Q1 2023 May 04, 2023	BUY	$39.51 - $61.95 $1.85 Million - $2.91 Million	46,920 Added 465.89%	56,991 $2.54 Million
Q4 2022 Feb 13, 2023	SELL	$38.6 - $62.07 $164,744 - $264,914	-4,268 Reduced 29.76%	10,071 $586,000
Q3 2022 Nov 03, 2022	BUY	$42.86 - $77.02 $89,277 - $160,432	2,083 Added 17.0%	14,339 $615,000
Q2 2022 Aug 12, 2022	BUY	$64.69 - $85.07 $770,651 - $1.01 Million	11,913 Added 3473.18%	12,256 $884,000
Q1 2022 May 16, 2022	SELL	$76.3 - $103.81 $1.08 Million - $1.46 Million	-14,110 Reduced 97.63%	343 $28,000
Q4 2021 Feb 14, 2022	SELL	$92.98 - $124.15 $1.95 Million - $2.6 Million	-20,981 Reduced 59.21%	14,453 $1.49 Million
Q3 2021 Nov 09, 2021	SELL	$77.49 - $109.17 $8.61 Million - $12.1 Million	-111,148 Reduced 75.83%	35,434 $3.63 Million
Q2 2021 Aug 13, 2021	SELL	$86.59 - $107.47 $864,427 - $1.07 Million	-9,983 Reduced 6.38%	146,582 $14 Million
Q1 2021 May 13, 2021	BUY	$66.32 - $90.93 $1.74 Million - $2.39 Million	26,270 Added 20.16%	156,565 $12.8 Million
Q4 2020 Feb 11, 2021	BUY	$46.7 - $75.22 $1.69 Million - $2.72 Million	36,122 Added 38.36%	130,295 $8.84 Million
Q3 2020 Nov 12, 2020	BUY	$42.77 - $56.69 $805,059 - $1.07 Million	18,823 Added 24.98%	94,173 $4.36 Million
Q2 2020 Aug 12, 2020	SELL	$26.54 - $44.24 $439,290 - $732,260	-16,552 Reduced 18.01%	75,350 $3.33 Million
Q1 2020 May 13, 2020	SELL	$22.69 - $44.14 $401,454 - $780,969	-17,693 Reduced 16.14%	91,902 $2.8 Million
Q4 2019 Feb 10, 2020	BUY	$35.49 - $48.05 $1.39 Million - $1.88 Million	39,092 Added 55.45%	109,595 $4.6 Million
Q3 2019 Nov 14, 2019	SELL	$30.18 - $41.75 $612,835 - $847,775	-20,306 Reduced 22.36%	70,503 $2.61 Million
Q2 2019 Aug 14, 2019	BUY	$29.53 - $41.1 $1.23 Million - $1.71 Million	41,533 Added 84.29%	90,809 $3.52 Million
Q1 2019 May 15, 2019	BUY	$24.38 - $33.75 $542,771 - $751,376	22,263 Added 82.42%	49,276 $1.45 Million
Q4 2018 Feb 14, 2019	SELL	$23.22 - $35.29 $1.08 Million - $1.64 Million	-46,583 Reduced 63.3%	27,013 $707,000
Q3 2018 Nov 14, 2018	BUY	$28.71 - $39.6 $1.37 Million - $1.9 Million	47,866 Added 186.03%	73,596 $2.58 Million
Q2 2018 Aug 14, 2018	BUY	$24.88 - $36.36 $105,516 - $154,202	4,241 Added 19.74%	25,730 $839,000
Q1 2018 May 15, 2018	BUY	$23.3 - $30.15 $127,590 - $165,101	5,476 Added 34.2%	21,489 $582,000
Q4 2017 Feb 14, 2018	BUY	$22.54 - $34.39 $279,248 - $426,057	12,389 Added 341.86%	16,013 $382,000
Q3 2017 Nov 14, 2017	BUY	$22.6 - $30.36 $81,902 - $110,024	3,624	3,624 $109,000

Others Institutions Holding AZTA

# of Institutions

337

Shares Held

51.4M

Call Options Held

237K

Put Options Held

302K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $2.74B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account